Current issues with β2-adrenoceptor agonists -: Pharmacology and molecular and cellular mechanisms

被引:49
作者
Anderson, Gary P. [1 ]
机构
[1] Univ Melbourne, Dept Med & Pharmacol, Cooperat Res Ctr Chron Inflammatory Dis, Lung Dis Res Grp, Parkville, Vic 3052, Australia
关键词
beta(2)-adrenoreceptor; lung; tachyphylaxis; signal transduction; LABAs;
D O I
10.1385/CRIAI:31:2:119
中图分类号
R392 [医学免疫学];
学科分类号
100102 [免疫学];
摘要
beta(2)-Adrenoceptors are widely, almost ubiquitously, expressed. Activation of these receptors on bronchial smooth muscle by short- and long-acting beta(2)-adrenoceptor agonists causes bronchodilation. Here, the beta(2)-adrenoceptor is linked by the G protein, Gs, to adenylyl cyclase, which increases cyclic adenosine monophosphate (cAMP), thus activating protein kinase A, which affects calcium levels and reduces the efficiency of myosin light-chain kinase, causing relaxation. Activation also entrains numerous acute and longer term downregulation responses affecting the number, location, and net efficiency of signaling of the receptor. Synthetic beta(2)-agonists are all "partial agonists," incompletely able to optimally stimulate cAMP signal transduction. However, compared with some cells (such as mast cells) involved in exercise-induced asthma induction, airway smooth muscle is privileged in that transduction efficiency is intrinsically high and the tissue is very resistant to complete downregulation. Glucocorticosteroids have broadly beneficial interactions with beta(2)-adrenoceptors. Researchers have recently discovered that the beta(2)-adrenoceptor may function as a homodimer and that it can form heterodimers with both the beta(1)- and beta(3)-adrenoceptors, and possibly other receptors. This further complicates interpretation of the effect of beta(2)-adrenoceptor polymorphisms, but it is unknown whether this occurs in humans in vivo. Researchers have known for some time that strong contraction involving receptors coupled to the Gq G protein (e.g., cholinergic and leukotriene receptors via negative biochemical crosstalk), virus infection (via uncoupling), and inflammation (via kinases) can impair relaxation. Most recently, researchers have discovered that the beta(2)-adrenoceptor can also send potentially adverse signals after "atypical coupling" to Gq rather than Gs. The clinical implications of these uncouplings, crosstalk, and atypical coupling possibilities are not well-understood.
引用
收藏
页码:119 / 130
页数:12
相关论文
共 79 条
[1]
WHY ARE LONG-ACTING BETA-ADRENOCEPTOR AGONISTS LONG-ACTING [J].
ANDERSON, GP ;
LINDEN, A ;
RABE, KF .
EUROPEAN RESPIRATORY JOURNAL, 1994, 7 (03) :569-578
[2]
FORMOTEROL - PHARMACOLOGY, MOLECULAR-BASIS OF AGONISM, AND MECHANISM OF LONG-DURATION OF A HIGHLY POTENT AND SELECTIVE BETA(2)-ADRENOCEPTOR AGONIST BRONCHODILATOR [J].
ANDERSON, GP .
LIFE SCIENCES, 1993, 52 (26) :2145-2160
[3]
Interactions between corticosteroids and β-adrenergic agonists in asthma disease induction, progression, and exacerbation [J].
Anderson, GP .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (03) :S188-S196
[4]
ANDERSON GP, 1993, AGENT ACTION SUPPL, V43, P253
[5]
Subsensitivity to bronchoprotection against adenosine monophosphate challenge following regular once-daily formoterol [J].
Aziz, I ;
Tan, KS ;
Hall, IP ;
Devlin, MM ;
Lipworth, BJ .
EUROPEAN RESPIRATORY JOURNAL, 1998, 12 (03) :580-584
[6]
ABNORMALITIES IN AIRWAY SMOOTH-MUSCLE IN FATAL ASTHMA - A COMPARISON BETWEEN TRACHEA AND BRONCHUS [J].
BAI, TR .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 143 (02) :441-443
[7]
A COMPARISON OF BETA-ADRENERGIC RECEPTORS AND INVITRO RELAXANT RESPONSES TO ISOPROTERENOL IN ASTHMATIC AIRWAY SMOOTH-MUSCLE [J].
BAI, TR ;
MAK, JCW ;
BARNES, PJ .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1992, 6 (06) :647-651
[8]
DOSE-RESPONSE CURVES TO INHALED BETA-ADRENOCEPTOR AGONISTS IN NORMAL AND ASTHMATIC SUBJECTS [J].
BARNES, PJ ;
PRIDE, NB .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (06) :677-682
[9]
BETA-ADRENOCEPTORS ON SMOOTH-MUSCLE, NERVES AND INFLAMMATORY CELLS [J].
BARNES, PJ .
LIFE SCIENCES, 1993, 52 (26) :2101-2109
[10]
Several studies have shown salmeterol to be more potent than salbutamol for systemic effects [J].
Bennett, J ;
Tattersfield, AE .
BRITISH MEDICAL JOURNAL, 1997, 315 (7100) :121-121